BioMark Diagnostics Long Term Debt

The latest long-term debt for BMKDF is $930K as of June 2026. That compares with $100K in the prior-year period — up 818.0% year over year. Investors often review this figure alongside BioMark Diagnostics's historical trend and sector peers before judging valuation or financial health.

Over the past year, BMKDF's long-term debt moved from $100K to $930K — a 818.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BioMark Diagnostics's operating scale or balance-sheet position.

A long-term debt figure of $930K for BMKDF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BMKDF's long-term debt ($930K), review year-over-year change from $100K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.